JP2006504636A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504636A5
JP2006504636A5 JP2004508943A JP2004508943A JP2006504636A5 JP 2006504636 A5 JP2006504636 A5 JP 2006504636A5 JP 2004508943 A JP2004508943 A JP 2004508943A JP 2004508943 A JP2004508943 A JP 2004508943A JP 2006504636 A5 JP2006504636 A5 JP 2006504636A5
Authority
JP
Japan
Prior art keywords
aqueous
composition
polysaccharide
polymer
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004508943A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504636A (ja
Filing date
Publication date
Priority claimed from US10/291,327 external-priority patent/US6998393B2/en
Application filed filed Critical
Publication of JP2006504636A publication Critical patent/JP2006504636A/ja
Publication of JP2006504636A5 publication Critical patent/JP2006504636A5/ja
Pending legal-status Critical Current

Links

JP2004508943A 2002-06-03 2003-06-03 構造的に脆弱な薬剤のための無障害のマイクロカプセル化、及び安定水性−水性乳剤の応用 Pending JP2006504636A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38497102P 2002-06-03 2002-06-03
US41810002P 2002-10-11 2002-10-11
US10/291,327 US6998393B2 (en) 2000-06-23 2002-11-08 Aquespheres, their preparation and uses thereof
PCT/CN2003/000431 WO2003101600A2 (en) 2002-06-03 2003-06-03 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion

Publications (2)

Publication Number Publication Date
JP2006504636A JP2006504636A (ja) 2006-02-09
JP2006504636A5 true JP2006504636A5 (OSRAM) 2006-07-20

Family

ID=27404043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004508943A Pending JP2006504636A (ja) 2002-06-03 2003-06-03 構造的に脆弱な薬剤のための無障害のマイクロカプセル化、及び安定水性−水性乳剤の応用

Country Status (7)

Country Link
US (2) US6998393B2 (OSRAM)
EP (1) EP1572341A4 (OSRAM)
JP (1) JP2006504636A (OSRAM)
CN (1) CN102247327A (OSRAM)
AU (1) AU2003245804A1 (OSRAM)
CA (1) CA2487867A1 (OSRAM)
WO (1) WO2003101600A2 (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998393B2 (en) * 2000-06-23 2006-02-14 Biopharm Solutions, Inc. Aquespheres, their preparation and uses thereof
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
BRPI0404983A (pt) * 2004-09-03 2006-05-02 Nanocore Biotecnologia Ltda composições imunogênicas
MX2007013356A (es) * 2005-04-27 2008-03-26 Baxter Int Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
US20070015689A1 (en) * 2005-06-23 2007-01-18 Alza Corporation Complexation of metal ions with polypeptides
US8932633B2 (en) * 2005-08-29 2015-01-13 Biopharm Solutions Inc. Polysaccharide microparticles containing biological agents: their preparation and applications
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2008060786A2 (en) * 2006-10-06 2008-05-22 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
US9574128B2 (en) 2007-07-17 2017-02-21 Schlumberger Technology Corporation Polymer delivery in well treatment applications
US8043999B2 (en) * 2007-07-17 2011-10-25 Schlumberger Technology Corporation Stabilizing biphasic concentrates through the addition of small amounts of high molecular weight polyelectrolytes
US9475974B2 (en) * 2007-07-17 2016-10-25 Schlumberger Technology Corporation Controlling the stability of water in water emulsions
US7703527B2 (en) * 2007-11-26 2010-04-27 Schlumberger Technology Corporation Aqueous two-phase emulsion gel systems for zone isolation
US7703521B2 (en) * 2008-02-19 2010-04-27 Schlumberger Technology Corporation Polymeric microspheres as degradable fluid loss additives in oilfield applications
ES2385762T3 (es) 2008-09-30 2012-07-31 The Procter & Gamble Company Composición que comprende microcápsulas
US20100179076A1 (en) * 2009-01-15 2010-07-15 Sullivan Philip F Filled Systems From Biphasic Fluids
US7950459B2 (en) * 2009-01-15 2011-05-31 Schlumberger Technology Corporation Using a biphasic solution as a recyclable coiled tubing cleanout fluid
US20100184631A1 (en) * 2009-01-16 2010-07-22 Schlumberger Technology Corporation Provision of viscous compositions below ground
US20100184630A1 (en) * 2009-01-16 2010-07-22 Sullivan Philip F Breaking the rheology of a wellbore fluid by creating phase separation
WO2010102066A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Dextran polymer powder for inhalation administration of pharmaceuticals
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
JP5618307B2 (ja) * 2009-07-09 2014-11-05 国立大学法人九州大学 水溶性薬物キャリア及びその製造方法
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
EP2618924A1 (en) 2010-09-24 2013-07-31 Bend Research, Inc. High-temperature spray drying process and apparatus
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
PL2892524T3 (pl) 2012-09-04 2021-10-25 Eleison Pharmaceuticals, Llc Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
WO2016046845A1 (en) * 2014-09-25 2016-03-31 Manu Chaudhary Stealth, targeted nanoparticles (stn) for oral drug delivery
EP3212169B1 (en) 2014-10-31 2021-01-13 Bend Research, Inc. Process for forming active domains dispersed in a matrix
CN105571673B (zh) * 2015-12-11 2019-01-18 大连民族大学 一种脂质体包封体积的测定方法
CN105509836B (zh) * 2015-12-11 2019-01-18 大连民族大学 一种脂质体包封体积的快速测定方法
BR112018016774A2 (pt) 2016-02-16 2018-12-26 Strongbridge Ireland Limited veldoreotídeo com fraca solubilidade em condições fisiológicas para o uso no tratamento da acromegalia, câncer em acromegalia, tumores que expressam sst-r5, diabetes tipo 2, hiperglicemia e tumores relacionados a hormônio
EP3484450A4 (en) * 2016-07-18 2020-04-01 Tissuegen, Inc. METHODS AND COMPOSITIONS FOR MAINTAINING THE CONFORMATION AND STRUCTURAL INTEGRITY OF BIOMOLECULES
CN112203690A (zh) 2018-01-12 2021-01-08 哈佛大学校长及研究员协会 与具有粘附颗粒的巨噬细胞和/或单核细胞有关的组合物和方法
AU2020287620B2 (en) * 2019-06-07 2025-12-18 President And Fellows Of Harvard College Compositions and methods relating to erythrocytes with adhered particles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
US5716644A (en) 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5827707A (en) 1995-06-07 1998-10-27 Neocrin Company Method for manufacturing minimal volume capsules containing biological materials
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
DK1071407T3 (da) * 1999-01-18 2014-10-20 Lg Life Sciences Ltd Lipofile mikropartikler indeholdende et proteinlægemiddel eller et antigen og formulering omhandlende samme
US6998393B2 (en) * 2000-06-23 2006-02-14 Biopharm Solutions, Inc. Aquespheres, their preparation and uses thereof
US6805879B2 (en) * 2000-06-23 2004-10-19 Biopharm Solutions Inc. Stable polymer aqueous/aqueous emulsion system and uses thereof
SE0201599D0 (sv) * 2002-03-21 2002-05-30 Skyepharma Ab Microparticles

Similar Documents

Publication Publication Date Title
US6998393B2 (en) Aquespheres, their preparation and uses thereof
Abdelkader et al. Review on micro-encapsulation with Chitosan for pharmaceuticals applications
ES2204837T3 (es) Metodo para la preparacion de microesferas que contienen sistemas coloidales.
ES2286157T5 (es) Procedimiento de transición de fase inducida para la producción de micropartículas que contienen agentes activos hidrófobos
Lee et al. Long acting injectable formulations: the state of the arts and challenges of poly (lactic-co-glycolic acid) microsphere, hydrogel, organogel and liquid crystal
CN101217947B (zh) 包含壳聚糖和环糊精的纳米颗粒
EP1576952A1 (en) Hydrogel microspheres with improved release profile
JP5080453B2 (ja) 非経口投与に適したコアとマイクロカプセル並びにそれらの製造方法
Nair et al. Application of chitosan microspheres as drug carriers: a review
ES2492891T3 (es) Carboxipolisacáridos activados químicamente y usos
CN100352427C (zh) 用于可控释放给药的,含分子量降低的支链淀粉基纯化淀粉的可生物降解微粒
EP0941068B1 (en) Controlled release microspheres
CN111417459B (zh) 一种可载药微球及其制备方法
KR20140097541A (ko) 폴리머 약물-전달 물질, 이의 제조 방법 및 약물-전달 조성물을 전달하는 방법
Majcher et al. Hydrogel synthesis and design
KOFUJI et al. Biodegradation and drug release of chitosan gel beads in subcutaneous air pouches of mice
JP6121006B2 (ja) 安定剤として生分解性表面活性ブロックコポリマを含むマイクロカプセル化のためのエマルジョン
CN104055738A (zh) 利用具有溶胶-凝胶转变特性的聚合物制备微球的方法以及由此制备的微球
CN1907270A (zh) 低温水相－水相乳液制备蛋白质－多糖玻璃体缓释微球的方法
Guerrero et al. Preparation of crosslinked alginate-cellulose derivative microparticles for protein delivery
Lin et al. Characterization of protein-loaded poly (?-caprolactone microparticles based on a factorial design
WO2004006893A1 (en) Method for particle precipitation using near-critical and supercritical antisolvents
CN101115468A (zh) 用于结构易变的试剂的无副作用微囊包封技术及水相-水相乳剂的应用
Pitt The controlled delivery of polypeptides including LHRH analogs
Chiome et al. Silk Fibroin-Based Drug Delivery Systems